NCT02088203View on ClinicalTrials.gov

Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Diabetes Prevention
Interventions
DIETARY_SUPPLEMENT

Dose 1

Russian Tarragon Nutrasorb 0.3 g

DIETARY_SUPPLEMENT

Dose 2

Russian Tarragon Nutrasorb 1 g

DIETARY_SUPPLEMENT

Dose 0

Placebo

DIETARY_SUPPLEMENT

Dose 3

Russian Tarragon Nutrasorb 3 g

DIETARY_SUPPLEMENT

Dose 4

Russian Tarragon Nutrasorb 10 g

DIETARY_SUPPLEMENT

Dose 5

Russian Tarragon Nutrasorb 20 g

DIETARY_SUPPLEMENT

Dose 6

Russian Tarragon Nutrasorb 30 g

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Office of Dietary Supplements (ODS)

NIH

lead

Pennington Biomedical Research Center

OTHER

NCT02088203 - Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.) | Biotech Hunter | Biotech Hunter